Venture-Backed Startups

Cell4Food develops cellular agriculture technology to produce seafood—including fish, mollusks, and crustaceans—from cell cultures using bioreactors. The company targets sustainable food production with lower environmental impact than traditional aquaculture.

1 investor

Cella accelerates the natural geologic process that turns carbon dioxide into a mineral by injecting captured atmospheric CO2 into volcanic rock, where mineralization permanently stores it underground. The company provides carbon storage technology designed to scale alongside carbon capture across varied geologic settings.

1 investor

0 investors

0 investors

Cellanome develops a live-cell analysis platform using CellCage technology to create controlled microenvironments that enable researchers to observe cell behavior and molecular changes over time. The platform generates structured multimodal data for life sciences researchers and biopharma companies focused on oncology, neuroscience, immunology, and aging research.

4 investors

Cellar Insights offers a smart remote monitoring system that detects rot gas and adverse storage conditions to help potato growers, processors, and storage operators reduce spoilage, shrink, and quality loss. The platform provides sensors, alerts, trend data, and analytics, with hardware installation, maintenance, and support included.

4 investors

0 investors

CellaraRx analyzes tumor biology at the single-cell level to predict whether a patient is likely to respond to a cancer treatment before clinical trial enrollment. It serves drug developers, pharma investors, and clinicians by identifying treatment-resistant cells and improving patient selection for oncology drug trials.

1 investor

Cellares develops automated manufacturing systems and technology platforms to accelerate the production and commercialization of cell therapies. The company serves biopharmaceutical manufacturers and cell therapy developers worldwide.

5 investors

0 investors

0 investors

0 investors

Cellarim produces beauty and skincare ingredients using enzymatic, cell-free synthesis rather than extraction, fermentation, or conventional chemical methods. It positions its enzyme-based approach as a way to make purer, more scalable, and more sustainable cosmetic ingredients.

1 investor

Cellarity develops therapeutics using AI-powered multi-omics analysis to identify and correct dysfunctional cellular states, treating complex diseases by regulating genetic pathways rather than targeting single genes.

3 investors

CellaVision develops digital hematology microscopy solutions—including analyzers, instruments, reagents, and software—that automate cell morphology workflows in hematology laboratories for human and animal blood and body fluid samples. It serves clinical and veterinary hematology labs of all sizes across more than 40 countries.

1 investor

Xcell Biosciences develops the AVATAR platform, which integrates physiologic oxygen and pressure control into cell therapy R&D and GMP manufacturing workflows to condition cells for the tumor microenvironment. Its systems provide closed, automated scale-up and label-free potency data aimed at improving solid tumor cell and gene therapy development.

2 investors

Cell Bio Engines is a company founded by scientist-entrepreneurs developing scientific solutions and products. The team page does not specify the concrete products, target customers, or industry focus.

1 investor

Cellbox Solutions develops portable incubators with active CO₂ and temperature control to transport living cells and biological samples at constant laboratory conditions (37°C, 5% CO₂). The company serves the global biomedical industry and works with over 150 customers on cell transport logistics.

1 investor

CellBri develops tools and automation technologies for cell therapy development workflows, covering stages from benchtop preparation to full-suite processing. Its products are aimed at organizations scaling cell therapy operations.

1 investor

Cellbricks Therapeutics develops cell-based human tissue therapeutics using light-based biofabrication and AI-driven tissue engineering software to treat tissue dysfunction and organ failure. The company produces scalable, functional tissue implants designed to restore lost tissue and organ function for patients with no existing treatment options.

2 investors

Cellbricks is a tissue therapeutics company developing cell-based human tissue implants using light-based biofabrication and AI-driven tissue engineering to restore soft tissue defects and organ function. It targets patients with conditions caused by tissue dysfunction that lack reliable treatment options.

2 investors

Cellbyte automates regulatory workflows and data analysis for pharmaceutical drug launches, helping manufacturers prepare treatments for global markets faster.

3 investors

CellCentric is a clinical-stage biopharmaceutical company developing inobrodib, an oral small molecule inhibitor of the p300/CBP proteins, for the treatment of multiple myeloma and other cancers. The drug is being evaluated in clinical trials, including in combination with standard-of-care therapies for use in community care settings.

2 investors

0 investors